SLW Institute

SLW Institute

Looking for educational content on intellectual property? The Schwegman firm has developed the SLW Institute, aimed to deliver educational and training content in a variety of ways for you to advance your IP knowledge.

Blog

PATENTS4LIFE

05/24/2019

Patents4Life

Bipartisan "Draft Bill" to Amend ss. 100, 101 and 112 Released for Comment

Claims of Uniloc Patents Covering a Software Distribution System Found Patent Eligible by Federal Circuit

Novartis v. West-Ward – Lead Compound Analysis v. Motivation to Combine

Is the “Blocking Patent” Doctrine Part of the Obviousness Analysis?

According to Anticipat, the PTAB has Set Another Record for Reversing Abstract Idea Rejections

Athena III – Should the Discovery of a Naturally-Occurring Correlation Encompass Recognition of its Practical Utility?

IP Playbook

05/06/2019

Patent Procurement & Management

Senate Committee Releases Outline for Section 101 Reform

Athena’s Petition for Rehearing En Banc – Not All Diagnostic Claims are Equal Under s. 101

IP Playbook

04/08/2019

Copyright & Personality Rights

Cleveland Clinic II – Why Can’t a Diagnostic Conclusion be a Practical Application of a Natural Law?

Schwegman Lundberg & Woessner

Schwegman Lundberg & Woessner

Filter Resources

Resources By Type

Resources By Topic

Bipartisan "Draft Bill" to Amend ss. 100, 101 and 112 Released for Comment

Claims of Uniloc Patents Covering a Software Distribution System Found Patent Eligible by Federal Circuit

Novartis v. West-Ward – Lead Compound Analysis v. Motivation to Combine

Is the “Blocking Patent” Doctrine Part of the Obviousness Analysis?

According to Anticipat, the PTAB has Set Another Record for Reversing Abstract Idea Rejections

Athena III – Should the Discovery of a Naturally-Occurring Correlation Encompass Recognition of its Practical Utility?

Patent Procurement & Management

Senate Committee Releases Outline for Section 101 Reform

Athena’s Petition for Rehearing En Banc – Not All Diagnostic Claims are Equal Under s. 101

Copyright & Personality Rights

Cleveland Clinic II – Why Can’t a Diagnostic Conclusion be a Practical Application of a Natural Law?

Endo v. Teva – Correlation Diagnostic Plus Treatment is Patent Eligible under s. 101

Schwegman Lundberg & Woessner

SLW Institute

Filter Resources

Resources By Type

Resources By Topic

Subscribe

Bipartisan "Draft Bill" to Amend ss. 100, 101 and 112 Released for Comment

Claims of Uniloc Patents Covering a Software Distribution System Found Patent Eligible by Federal Circuit

Novartis v. West-Ward – Lead Compound Analysis v. Motivation to Combine

Is the “Blocking Patent” Doctrine Part of the Obviousness Analysis?

According to Anticipat, the PTAB has Set Another Record for Reversing Abstract Idea Rejections

Athena III – Should the Discovery of a Naturally-Occurring Correlation Encompass Recognition of its Practical Utility?

Patent Procurement & Management

Senate Committee Releases Outline for Section 101 Reform

Athena’s Petition for Rehearing En Banc – Not All Diagnostic Claims are Equal Under s. 101

Copyright & Personality Rights

Cleveland Clinic II – Why Can’t a Diagnostic Conclusion be a Practical Application of a Natural Law?

Endo v. Teva – Correlation Diagnostic Plus Treatment is Patent Eligible under s. 101